0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pet Meds and Supplements Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-6D9839
Home | Market Reports | Pets & Animals| Animal Products & Services| Pet Food & Supplies
Global Pet Meds and Supplements Market Research Report 2022
BUY CHAPTERS

Global Pet Meds and Supplements Market Research Report 2025

Code: QYRE-Auto-6D9839
Report
March 2025
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pet Meds and Supplements Market Size

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%.

Pet Meds and Supplements Market

Pet Meds and Supplements Market

The global market for Pet Meds and Supplements was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 45%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pet Meds and Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Meds and Supplements.
The Pet Meds and Supplements market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Meds and Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Meds and Supplements manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pet Meds and Supplements Market Report

Report Metric Details
Report Name Pet Meds and Supplements Market
Accounted market size in 2022 $ 261 billion
Base Year 2022
Segment by Type
  • External Use
  • Oral Use
Segment by Application
  • Dogs
  • Cats
  • Rabbit
  • Bird
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health, Dechra Pharmaceuticals, Zoetis, Merck, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences, Dechra Veterinary Products, Ouro Fino Saude, Norbrook, Frontline, Zesty Paws
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pet Meds and Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pet Meds and Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pet Meds and Supplements Market report?

Ans: The main players in the Pet Meds and Supplements Market are Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health, Dechra Pharmaceuticals, Zoetis, Merck, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences, Dechra Veterinary Products, Ouro Fino Saude, Norbrook, Frontline, Zesty Paws

What are the Application segmentation covered in the Pet Meds and Supplements Market report?

Ans: The Applications covered in the Pet Meds and Supplements Market report are Dogs, Cats, Rabbit, Bird, Others

What are the Type segmentation covered in the Pet Meds and Supplements Market report?

Ans: The Types covered in the Pet Meds and Supplements Market report are External Use, Oral Use

Recommended Reports

Pet Healthcare Products

Pet Foods & Supplements

Veterinary & Animal Testing

1 Pet Meds and Supplements Market Overview
1.1 Product Definition
1.2 Pet Meds and Supplements by Type
1.2.1 Global Pet Meds and Supplements Market Value Comparison by Type (2024 VS 2031)
1.2.2 External Use
1.2.3 Oral Use
1.3 Pet Meds and Supplements by Application
1.3.1 Global Pet Meds and Supplements Market Value by Application (2024 VS 2031)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Rabbit
1.3.5 Bird
1.3.6 Others
1.4 Global Pet Meds and Supplements Market Size Estimates and Forecasts
1.4.1 Global Pet Meds and Supplements Revenue 2020-2031
1.4.2 Global Pet Meds and Supplements Sales 2020-2031
1.4.3 Global Pet Meds and Supplements Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pet Meds and Supplements Market Competition by Manufacturers
2.1 Global Pet Meds and Supplements Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pet Meds and Supplements Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pet Meds and Supplements Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pet Meds and Supplements, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Meds and Supplements, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Meds and Supplements, Product Type & Application
2.7 Global Key Manufacturers of Pet Meds and Supplements, Date of Enter into This Industry
2.8 Global Pet Meds and Supplements Market Competitive Situation and Trends
2.8.1 Global Pet Meds and Supplements Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pet Meds and Supplements Players Market Share by Revenue
2.8.3 Global Pet Meds and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pet Meds and Supplements Market Scenario by Region
3.1 Global Pet Meds and Supplements Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pet Meds and Supplements Sales by Region: 2020-2031
3.2.1 Global Pet Meds and Supplements Sales by Region: 2020-2025
3.2.2 Global Pet Meds and Supplements Sales by Region: 2026-2031
3.3 Global Pet Meds and Supplements Revenue by Region: 2020-2031
3.3.1 Global Pet Meds and Supplements Revenue by Region: 2020-2025
3.3.2 Global Pet Meds and Supplements Revenue by Region: 2026-2031
3.4 North America Pet Meds and Supplements Market Facts & Figures by Country
3.4.1 North America Pet Meds and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pet Meds and Supplements Sales by Country (2020-2031)
3.4.3 North America Pet Meds and Supplements Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Meds and Supplements Market Facts & Figures by Country
3.5.1 Europe Pet Meds and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pet Meds and Supplements Sales by Country (2020-2031)
3.5.3 Europe Pet Meds and Supplements Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Meds and Supplements Market Facts & Figures by Region
3.6.1 Asia Pacific Pet Meds and Supplements Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pet Meds and Supplements Sales by Region (2020-2031)
3.6.3 Asia Pacific Pet Meds and Supplements Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Meds and Supplements Market Facts & Figures by Country
3.7.1 Latin America Pet Meds and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pet Meds and Supplements Sales by Country (2020-2031)
3.7.3 Latin America Pet Meds and Supplements Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Meds and Supplements Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Meds and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pet Meds and Supplements Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pet Meds and Supplements Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pet Meds and Supplements Sales by Type (2020-2031)
4.1.1 Global Pet Meds and Supplements Sales by Type (2020-2025)
4.1.2 Global Pet Meds and Supplements Sales by Type (2026-2031)
4.1.3 Global Pet Meds and Supplements Sales Market Share by Type (2020-2031)
4.2 Global Pet Meds and Supplements Revenue by Type (2020-2031)
4.2.1 Global Pet Meds and Supplements Revenue by Type (2020-2025)
4.2.2 Global Pet Meds and Supplements Revenue by Type (2026-2031)
4.2.3 Global Pet Meds and Supplements Revenue Market Share by Type (2020-2031)
4.3 Global Pet Meds and Supplements Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pet Meds and Supplements Sales by Application (2020-2031)
5.1.1 Global Pet Meds and Supplements Sales by Application (2020-2025)
5.1.2 Global Pet Meds and Supplements Sales by Application (2026-2031)
5.1.3 Global Pet Meds and Supplements Sales Market Share by Application (2020-2031)
5.2 Global Pet Meds and Supplements Revenue by Application (2020-2031)
5.2.1 Global Pet Meds and Supplements Revenue by Application (2020-2025)
5.2.2 Global Pet Meds and Supplements Revenue by Application (2026-2031)
5.2.3 Global Pet Meds and Supplements Revenue Market Share by Application (2020-2031)
5.3 Global Pet Meds and Supplements Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Pet Meds and Supplements Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Ceva Sante Animale
6.2.1 Ceva Sante Animale Company Information
6.2.2 Ceva Sante Animale Description and Business Overview
6.2.3 Ceva Sante Animale Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ceva Sante Animale Pet Meds and Supplements Product Portfolio
6.2.5 Ceva Sante Animale Recent Developments/Updates
6.3 Bimeda Animal Health
6.3.1 Bimeda Animal Health Company Information
6.3.2 Bimeda Animal Health Description and Business Overview
6.3.3 Bimeda Animal Health Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bimeda Animal Health Pet Meds and Supplements Product Portfolio
6.3.5 Bimeda Animal Health Recent Developments/Updates
6.4 Dechra Pharmaceuticals
6.4.1 Dechra Pharmaceuticals Company Information
6.4.2 Dechra Pharmaceuticals Description and Business Overview
6.4.3 Dechra Pharmaceuticals Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dechra Pharmaceuticals Pet Meds and Supplements Product Portfolio
6.4.5 Dechra Pharmaceuticals Recent Developments/Updates
6.5 Zoetis
6.5.1 Zoetis Company Information
6.5.2 Zoetis Description and Business Overview
6.5.3 Zoetis Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zoetis Pet Meds and Supplements Product Portfolio
6.5.5 Zoetis Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Pet Meds and Supplements Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Elanco
6.7.1 Elanco Company Information
6.7.2 Elanco Description and Business Overview
6.7.3 Elanco Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Elanco Pet Meds and Supplements Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Company Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bayer Pet Meds and Supplements Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Boehringer
6.9.1 Boehringer Company Information
6.9.2 Boehringer Description and Business Overview
6.9.3 Boehringer Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boehringer Pet Meds and Supplements Product Portfolio
6.9.5 Boehringer Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Pet Meds and Supplements Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Virbac
6.11.1 Virbac Company Information
6.11.2 Virbac Description and Business Overview
6.11.3 Virbac Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Virbac Pet Meds and Supplements Product Portfolio
6.11.5 Virbac Recent Developments/Updates
6.12 Ceva
6.12.1 Ceva Company Information
6.12.2 Ceva Description and Business Overview
6.12.3 Ceva Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ceva Pet Meds and Supplements Product Portfolio
6.12.5 Ceva Recent Developments/Updates
6.13 Vetoquinol
6.13.1 Vetoquinol Company Information
6.13.2 Vetoquinol Description and Business Overview
6.13.3 Vetoquinol Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Vetoquinol Pet Meds and Supplements Product Portfolio
6.13.5 Vetoquinol Recent Developments/Updates
6.14 Nexvet
6.14.1 Nexvet Company Information
6.14.2 Nexvet Description and Business Overview
6.14.3 Nexvet Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Nexvet Pet Meds and Supplements Product Portfolio
6.14.5 Nexvet Recent Developments/Updates
6.15 Aratana Therapeutics
6.15.1 Aratana Therapeutics Company Information
6.15.2 Aratana Therapeutics Description and Business Overview
6.15.3 Aratana Therapeutics Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Aratana Therapeutics Pet Meds and Supplements Product Portfolio
6.15.5 Aratana Therapeutics Recent Developments/Updates
6.16 Kindred Biosciences
6.16.1 Kindred Biosciences Company Information
6.16.2 Kindred Biosciences Description and Business Overview
6.16.3 Kindred Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Kindred Biosciences Pet Meds and Supplements Product Portfolio
6.16.5 Kindred Biosciences Recent Developments/Updates
6.17 Ambrx
6.17.1 Ambrx Company Information
6.17.2 Ambrx Description and Business Overview
6.17.3 Ambrx Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Ambrx Pet Meds and Supplements Product Portfolio
6.17.5 Ambrx Recent Developments/Updates
6.18 Entest Biomedical
6.18.1 Entest Biomedical Company Information
6.18.2 Entest Biomedical Description and Business Overview
6.18.3 Entest Biomedical Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Entest Biomedical Pet Meds and Supplements Product Portfolio
6.18.5 Entest Biomedical Recent Developments/Updates
6.19 Taconic Biosciences
6.19.1 Taconic Biosciences Company Information
6.19.2 Taconic Biosciences Description and Business Overview
6.19.3 Taconic Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Taconic Biosciences Pet Meds and Supplements Product Portfolio
6.19.5 Taconic Biosciences Recent Developments/Updates
6.20 Dechra Veterinary Products
6.20.1 Dechra Veterinary Products Company Information
6.20.2 Dechra Veterinary Products Description and Business Overview
6.20.3 Dechra Veterinary Products Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Dechra Veterinary Products Pet Meds and Supplements Product Portfolio
6.20.5 Dechra Veterinary Products Recent Developments/Updates
6.21 Ouro Fino Saude
6.21.1 Ouro Fino Saude Company Information
6.21.2 Ouro Fino Saude Description and Business Overview
6.21.3 Ouro Fino Saude Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Ouro Fino Saude Pet Meds and Supplements Product Portfolio
6.21.5 Ouro Fino Saude Recent Developments/Updates
6.22 Norbrook
6.22.1 Norbrook Company Information
6.22.2 Norbrook Description and Business Overview
6.22.3 Norbrook Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Norbrook Pet Meds and Supplements Product Portfolio
6.22.5 Norbrook Recent Developments/Updates
6.23 Frontline
6.23.1 Frontline Company Information
6.23.2 Frontline Description and Business Overview
6.23.3 Frontline Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Frontline Pet Meds and Supplements Product Portfolio
6.23.5 Frontline Recent Developments/Updates
6.24 Zesty Paws
6.24.1 Zesty Paws Company Information
6.24.2 Zesty Paws Description and Business Overview
6.24.3 Zesty Paws Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Zesty Paws Pet Meds and Supplements Product Portfolio
6.24.5 Zesty Paws Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Meds and Supplements Industry Chain Analysis
7.2 Pet Meds and Supplements Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Meds and Supplements Production Mode & Process Analysis
7.4 Pet Meds and Supplements Sales and Marketing
7.4.1 Pet Meds and Supplements Sales Channels
7.4.2 Pet Meds and Supplements Distributors
7.5 Pet Meds and Supplements Customer Analysis
8 Pet Meds and Supplements Market Dynamics
8.1 Pet Meds and Supplements Industry Trends
8.2 Pet Meds and Supplements Market Drivers
8.3 Pet Meds and Supplements Market Challenges
8.4 Pet Meds and Supplements Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pet Meds and Supplements Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pet Meds and Supplements Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pet Meds and Supplements Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pet Meds and Supplements Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pet Meds and Supplements Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pet Meds and Supplements Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pet Meds and Supplements Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pet Meds and Supplements Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pet Meds and Supplements, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pet Meds and Supplements, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pet Meds and Supplements, Product Type & Application
 Table 12. Global Key Manufacturers of Pet Meds and Supplements, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pet Meds and Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Meds and Supplements as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pet Meds and Supplements Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pet Meds and Supplements Sales by Region (2020-2025) & (Units)
 Table 18. Global Pet Meds and Supplements Sales Market Share by Region (2020-2025)
 Table 19. Global Pet Meds and Supplements Sales by Region (2026-2031) & (Units)
 Table 20. Global Pet Meds and Supplements Sales Market Share by Region (2026-2031)
 Table 21. Global Pet Meds and Supplements Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pet Meds and Supplements Revenue Market Share by Region (2020-2025)
 Table 23. Global Pet Meds and Supplements Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pet Meds and Supplements Revenue Market Share by Region (2026-2031)
 Table 25. North America Pet Meds and Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pet Meds and Supplements Sales by Country (2020-2025) & (Units)
 Table 27. North America Pet Meds and Supplements Sales by Country (2026-2031) & (Units)
 Table 28. North America Pet Meds and Supplements Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pet Meds and Supplements Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pet Meds and Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pet Meds and Supplements Sales by Country (2020-2025) & (Units)
 Table 32. Europe Pet Meds and Supplements Sales by Country (2026-2031) & (Units)
 Table 33. Europe Pet Meds and Supplements Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pet Meds and Supplements Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pet Meds and Supplements Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pet Meds and Supplements Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Pet Meds and Supplements Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Pet Meds and Supplements Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pet Meds and Supplements Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pet Meds and Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pet Meds and Supplements Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Pet Meds and Supplements Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Pet Meds and Supplements Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pet Meds and Supplements Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pet Meds and Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pet Meds and Supplements Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Pet Meds and Supplements Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Pet Meds and Supplements Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pet Meds and Supplements Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pet Meds and Supplements Sales (Units) by Type (2020-2025)
 Table 51. Global Pet Meds and Supplements Sales (Units) by Type (2026-2031)
 Table 52. Global Pet Meds and Supplements Sales Market Share by Type (2020-2025)
 Table 53. Global Pet Meds and Supplements Sales Market Share by Type (2026-2031)
 Table 54. Global Pet Meds and Supplements Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pet Meds and Supplements Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pet Meds and Supplements Revenue Market Share by Type (2020-2025)
 Table 57. Global Pet Meds and Supplements Revenue Market Share by Type (2026-2031)
 Table 58. Global Pet Meds and Supplements Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pet Meds and Supplements Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pet Meds and Supplements Sales (Units) by Application (2020-2025)
 Table 61. Global Pet Meds and Supplements Sales (Units) by Application (2026-2031)
 Table 62. Global Pet Meds and Supplements Sales Market Share by Application (2020-2025)
 Table 63. Global Pet Meds and Supplements Sales Market Share by Application (2026-2031)
 Table 64. Global Pet Meds and Supplements Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pet Meds and Supplements Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pet Meds and Supplements Revenue Market Share by Application (2020-2025)
 Table 67. Global Pet Meds and Supplements Revenue Market Share by Application (2026-2031)
 Table 68. Global Pet Meds and Supplements Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pet Meds and Supplements Price (US$/Unit) by Application (2026-2031)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim Pet Meds and Supplements Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Ceva Sante Animale Company Information
 Table 76. Ceva Sante Animale Description and Business Overview
 Table 77. Ceva Sante Animale Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ceva Sante Animale Pet Meds and Supplements Product
 Table 79. Ceva Sante Animale Recent Developments/Updates
 Table 80. Bimeda Animal Health Company Information
 Table 81. Bimeda Animal Health Description and Business Overview
 Table 82. Bimeda Animal Health Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bimeda Animal Health Pet Meds and Supplements Product
 Table 84. Bimeda Animal Health Recent Developments/Updates
 Table 85. Dechra Pharmaceuticals Company Information
 Table 86. Dechra Pharmaceuticals Description and Business Overview
 Table 87. Dechra Pharmaceuticals Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Dechra Pharmaceuticals Pet Meds and Supplements Product
 Table 89. Dechra Pharmaceuticals Recent Developments/Updates
 Table 90. Zoetis Company Information
 Table 91. Zoetis Description and Business Overview
 Table 92. Zoetis Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Zoetis Pet Meds and Supplements Product
 Table 94. Zoetis Recent Developments/Updates
 Table 95. Merck Company Information
 Table 96. Merck Description and Business Overview
 Table 97. Merck Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Merck Pet Meds and Supplements Product
 Table 99. Merck Recent Developments/Updates
 Table 100. Elanco Company Information
 Table 101. Elanco Description and Business Overview
 Table 102. Elanco Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Elanco Pet Meds and Supplements Product
 Table 104. Elanco Recent Developments/Updates
 Table 105. Bayer Company Information
 Table 106. Bayer Description and Business Overview
 Table 107. Bayer Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bayer Pet Meds and Supplements Product
 Table 109. Bayer Recent Developments/Updates
 Table 110. Boehringer Company Information
 Table 111. Boehringer Description and Business Overview
 Table 112. Boehringer Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Boehringer Pet Meds and Supplements Product
 Table 114. Boehringer Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Novartis Pet Meds and Supplements Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Virbac Company Information
 Table 121. Virbac Description and Business Overview
 Table 122. Virbac Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Virbac Pet Meds and Supplements Product
 Table 124. Virbac Recent Developments/Updates
 Table 125. Ceva Company Information
 Table 126. Ceva Description and Business Overview
 Table 127. Ceva Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Ceva Pet Meds and Supplements Product
 Table 129. Ceva Recent Developments/Updates
 Table 130. Vetoquinol Company Information
 Table 131. Vetoquinol Description and Business Overview
 Table 132. Vetoquinol Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Vetoquinol Pet Meds and Supplements Product
 Table 134. Vetoquinol Recent Developments/Updates
 Table 135. Nexvet Company Information
 Table 136. Nexvet Description and Business Overview
 Table 137. Nexvet Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Nexvet Pet Meds and Supplements Product
 Table 139. Nexvet Recent Developments/Updates
 Table 140. Aratana Therapeutics Company Information
 Table 141. Aratana Therapeutics Description and Business Overview
 Table 142. Aratana Therapeutics Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Aratana Therapeutics Pet Meds and Supplements Product
 Table 144. Aratana Therapeutics Recent Developments/Updates
 Table 145. Kindred Biosciences Company Information
 Table 146. Kindred Biosciences Description and Business Overview
 Table 147. Kindred Biosciences Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Kindred Biosciences Pet Meds and Supplements Product
 Table 149. Kindred Biosciences Recent Developments/Updates
 Table 150. Ambrx Company Information
 Table 151. Ambrx Description and Business Overview
 Table 152. Ambrx Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Ambrx Pet Meds and Supplements Product
 Table 154. Ambrx Recent Developments/Updates
 Table 155. Entest Biomedical Company Information
 Table 156. Entest Biomedical Description and Business Overview
 Table 157. Entest Biomedical Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Entest Biomedical Pet Meds and Supplements Product
 Table 159. Entest Biomedical Recent Developments/Updates
 Table 160. Taconic Biosciences Company Information
 Table 161. Taconic Biosciences Description and Business Overview
 Table 162. Taconic Biosciences Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Taconic Biosciences Pet Meds and Supplements Product
 Table 164. Taconic Biosciences Recent Developments/Updates
 Table 165. Dechra Veterinary Products Company Information
 Table 166. Dechra Veterinary Products Description and Business Overview
 Table 167. Dechra Veterinary Products Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Dechra Veterinary Products Pet Meds and Supplements Product
 Table 169. Dechra Veterinary Products Recent Developments/Updates
 Table 170. Ouro Fino Saude Company Information
 Table 171. Ouro Fino Saude Description and Business Overview
 Table 172. Ouro Fino Saude Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Ouro Fino Saude Pet Meds and Supplements Product
 Table 174. Ouro Fino Saude Recent Developments/Updates
 Table 175. Norbrook Company Information
 Table 176. Norbrook Description and Business Overview
 Table 177. Norbrook Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Norbrook Pet Meds and Supplements Product
 Table 179. Norbrook Recent Developments/Updates
 Table 180. Frontline Company Information
 Table 181. Frontline Description and Business Overview
 Table 182. Frontline Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Frontline Pet Meds and Supplements Product
 Table 184. Frontline Recent Developments/Updates
 Table 185. Zesty Paws Company Information
 Table 186. Zesty Paws Description and Business Overview
 Table 187. Zesty Paws Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Zesty Paws Pet Meds and Supplements Product
 Table 189. Zesty Paws Recent Developments/Updates
 Table 190. Key Raw Materials Lists
 Table 191. Raw Materials Key Suppliers Lists
 Table 192. Pet Meds and Supplements Distributors List
 Table 193. Pet Meds and Supplements Customers List
 Table 194. Pet Meds and Supplements Market Trends
 Table 195. Pet Meds and Supplements Market Drivers
 Table 196. Pet Meds and Supplements Market Challenges
 Table 197. Pet Meds and Supplements Market Restraints
 Table 198. Research Programs/Design for This Report
 Table 199. Key Data Information from Secondary Sources
 Table 200. Key Data Information from Primary Sources
 Table 201. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pet Meds and Supplements
 Figure 2. Global Pet Meds and Supplements Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pet Meds and Supplements Market Share by Type: 2024 & 2031
 Figure 4. External Use Product Picture
 Figure 5. Oral Use Product Picture
 Figure 6. Global Pet Meds and Supplements Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pet Meds and Supplements Market Share by Application: 2024 & 2031
 Figure 8. Dogs
 Figure 9. Cats
 Figure 10. Rabbit
 Figure 11. Bird
 Figure 12. Others
 Figure 13. Global Pet Meds and Supplements Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pet Meds and Supplements Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Pet Meds and Supplements Sales (2020-2031) & (Units)
 Figure 16. Global Pet Meds and Supplements Average Price (US$/Unit) & (2020-2031)
 Figure 17. Pet Meds and Supplements Report Years Considered
 Figure 18. Pet Meds and Supplements Sales Share by Manufacturers in 2024
 Figure 19. Global Pet Meds and Supplements Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Pet Meds and Supplements Players: Market Share by Revenue in Pet Meds and Supplements in 2024
 Figure 21. Pet Meds and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Pet Meds and Supplements Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Pet Meds and Supplements Sales Market Share by Country (2020-2031)
 Figure 24. North America Pet Meds and Supplements Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Pet Meds and Supplements Sales Market Share by Country (2020-2031)
 Figure 28. Europe Pet Meds and Supplements Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Pet Meds and Supplements Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Pet Meds and Supplements Revenue Market Share by Region (2020-2031)
 Figure 36. China Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Pet Meds and Supplements Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Pet Meds and Supplements Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Pet Meds and Supplements Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Pet Meds and Supplements Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Pet Meds and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Pet Meds and Supplements by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Pet Meds and Supplements by Type (2020-2031)
 Figure 58. Global Pet Meds and Supplements Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Pet Meds and Supplements by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Pet Meds and Supplements by Application (2020-2031)
 Figure 61. Global Pet Meds and Supplements Price (US$/Unit) by Application (2020-2031)
 Figure 62. Pet Meds and Supplements Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS